Literature DB >> 10405418

Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay.

K Hirano1, C Abe, M Takahashi.   

Abstract

Mutations in the rpoB gene of 90 rifampin-resistant Mycobacterium tuberculosis isolates mostly from Asian countries were analyzed. Ten distinct single-nucleotide substitutions were found among the isolates by automated sequencing. A 3-nucleotide insertion was found in two isolates, and no mutation was found in five isolates (5.6%). A reverse hybridization-based line probe assay (INNO-LiPA Rif TB) for rapid detection of the mutations was evaluated with these isolates. Concordance rates with sequencing results for five wild-type probes (S probes) and four probes for specific mutations (R probes) were 96.7 and 100%, respectively. The overall concordance rate with the in vitro susceptibility testing results was 92.2% (83 of 90 isolates). These results indicate that a commercial line probe assay kit may be useful for rapid diagnosis of rifampin-resistant tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405418      PMCID: PMC85308     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

Review 1.  Tuberculosis in patients with human immunodeficiency virus infection.

Authors:  P F Barnes; A B Bloch; P T Davidson; D E Snider
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

2.  Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients.

Authors:  L Monno; G Angarano; S Carbonara; S Coppola; D Costa; M Quarto; G Pastore
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

3.  The new tuberculosis.

Authors:  D E Snider; W L Roper
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

4.  Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1991-08-30       Impact factor: 17.586

5.  Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City.

Authors:  R C Cooksey; G P Morlock; S Glickman; J T Crawford
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

6.  Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli.

Authors:  D J Jin; C A Gross
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

7.  Pyrazinamide susceptibility and amidase activity of tubercle bacilli.

Authors:  K Konno; F M Feldmann; W McDermott
Journal:  Am Rev Respir Dis       Date:  1967-03

8.  Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.

Authors:  D J Jin; C A Gross
Journal:  J Mol Biol       Date:  1988-07-05       Impact factor: 5.469

9.  Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis.

Authors:  K Hirano; M Takahashi; Y Kazumi; Y Fukasawa; C Abe
Journal:  Tuber Lung Dis       Date:  1997

10.  Use of pyrazinamidase activity on Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility.

Authors:  J K McClatchy; A Y Tsang; M S Cernich
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

View more
  47 in total

Review 1.  Molecular bacteriology: a diagnostic tool for the millennium.

Authors:  T L Pitt; N A Saunders
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

2.  Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India.

Authors:  C Mani; N Selvakumar; S Narayanan; P R Narayanan
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.

Authors:  Lishi Qian; Chiyoji Abe; Tao-Ping Lin; Ming-Chih Yu; Sang-Nae Cho; Sumin Wang; James T Douglas
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 4.  Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium.

Authors:  Armine M Sefton
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay.

Authors:  Z Bártfai; A Somoskövi; C Ködmön; N Szabó; E Puskás; L Kosztolányi; E Faragó; J Mester; L M Parsons; M Salfinger
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

6.  Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay.

Authors:  Cengiz Cavusoglu; Suleyha Hilmioglu; Sevinc Guneri; Altinay Bilgic
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China.

Authors:  Jun Yue; Wei Shi; Jingping Xie; Yao Li; Erliang Zeng; Honghai Wang
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay.

Authors:  Isik Somuncu Johansen; Bettina Lundgren; Anaida Sosnovskaja; Vibeke Østergaard Thomsen
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

9.  Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan.

Authors:  Ruwen Jou; Huang-Yau Chen; Chen-Yuan Chiang; Ming-Chih Yu; Ih-Jen Su
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Peptide nucleic acid-mediated competitive PCR clamping for detection of rifampin-resistant Mycobacterium tuberculosis.

Authors:  Tomotada Iwamoto; Toshiaki Sonobe
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.